HAROLD PAZ, Chief Executive Officer, Penn State Milton S. Hershey Medical Center, and Senior Vice President for Health Affairs and Dean, College of Medicine, Pennsylvania State University

CHARLES PEROU, Professor of Genetics and Pathology, and Member, Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill

PETER PRONOVOST, Director, Division of Adult Critical Care Medicine, Director, Quality and Safety Research Group, and Medical Director, Center for Innovations in Quality Patient Care, Johns Hopkins University

STEVEN SHAK, Chief Medical Officer, Genomic Health

RICHARD SIMON, Chief, Biometric Research Branch, National Cancer Institute

LAURA VAN ‘T VEER, Director, Applied Genomics, and Program Leader, Breast Oncology, Helen Diller Family Comprehensive Cancer Center

SCOTT ZEGER, Professor of Biostatistics and Vice Provost for Research, Bloomberg School of Public Health, Johns Hopkins University

COMMITTEE MEETING 3 – JUNE 30-JULY 1, 2011

LISA MCSHANE, Mathematical Statistician, Biometric Research Branch, National Cancer Institute

TELECONFERENCE 1 – AUGUST 4, 2011

WILLIAM SELLERS, Vice President and Global Head of Oncology, Novartis Institutes for BioMedical Research

TELECONFERENCE 2 – AUGUST 15, 2011

JEFFREY DRAZEN, Editor-in-Chief, New England Journal of Medicine

TELECONFERENCE 3 – AUGUST 19, 2011

ALBERTO GUTIERREZ, Director, Office of In Vitro Diagnostic Device Evaluation and Safety, Center for Devices and Radiological Health, Food and Drug Administration

PANEL DISCUSSION WITH DUKE UNIVERSITY FACULTY AND ADMINISTRATION – AUGUST 22, 2011

WILLIAM BARRY, Assistant Professor of Biostatistics and Bioinformatics



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement